Shabnam Shalapour

9PUBLICATIONS
64CO-AUTHORS
Molecular targetsCancer diagnosisHaematologyHaematological tumoursLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2026
Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer.

|Jun 27, 2024
Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer.

Krishnan K Mahadevan, Allison M Dyevoich, Yang Chen

|Oct 27, 2023
IRF1 regulates self-renewal and stress responsiveness to support hematopoietic stem cell maintenance.

Alexandra J S Rundberg Nilsson, Hongxu Xian, Shabnam Shalapour

|May 01, 2023
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.

Li Gu, Yahui Zhu, Maiya Lee

|Sep 13, 2022
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.

Dapeng Hao, Guangchun Han, Ansam Sinjab

|Mar 04, 2022
Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth.

Margot De Marco, Vanessa Gauttier, Sabrina Pengam

Pageof 2

Frequent Collaborators

3 joint publications

Michael Karin

2 joint publications

Raghu Kalluri

1 joint publications

Mark D Long

1 joint publications

Tao Liu